Medical News

RSS

Clinton defends State Department budget requests before House panel

In her testimony before the House Foreign Affairs Committee on Tuesday about President Barack Obama's FY12 budget request, Secretary of State Hillary Rodham Clinton also defended the State Department's FY11 budget request, Bloomberg reports. Clinton said the proposed budget cuts for FY11 would be "devastating" to U.S. national security, and U.S. programs in Afghanistan, Pakistan and Iraq would see "sharp reductions" if the proposed cuts are passed.

3 Mar 2011

Rockwell Medical fourth quarter net loss increases to $1.7 million

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, reported today fourth quarter and full-year 2010 results.

3 Mar 2011

Block grant plan among Medicaid alternatives eyed by GOP

Mississippi Gov. Haley Barbour is among those who advocate this concept, but the Obama administration's Medicaid chief "shot down" the approach.

3 Mar 2011

Protalex initiates enrollment in 3rd cohort of PRTX-100 Phase 1b dose escalation clinical study in RA

Protalex, Inc, a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and inflammatory diseases, today announced enrollment of the first patients in the 3rd cohort of its ongoing multicenter Phase 1b dose escalation clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA) being conducted in South Africa. The dose was increased by a factor of two from the 2nd cohort.

3 Mar 2011

EU's Avastin policy: A stark contrast to the FDA's recent decision

The committee's decision stands in stark contrast to the recent verdict by the U.S. Food and Drug Administration, which is wary of Avastin's benefits for breast-cancer patients.

3 Mar 2011

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.

3 Mar 2011

First Edition: March 3, 2011

Today's headlines highlight the difficulties lawmakers will face in finding a compromise on long-term budget issues, such as Medicare and Medicaid spending.

3 Mar 2011

EC grants marketing authorization for InterMune's Esbriet to treat IPF

InterMune, Inc. today announced that the European Commission has granted marketing authorization for Esbriet. Esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis, a progressive and fatal lung disease.

3 Mar 2011

'Implementation science' approach to play a critical role in next phase of PEPFAR program

An "implementation science" approach will play a critical role in the next phase of The U.S. President's Emergency Plan for AIDS Relief, according to an editorial in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

3 Mar 2011

Positive outcomes from Argos AGS-004 Phase 2a trial in patients with HIV

Argos Therapeutics announced today that its Arcelis immunotherapy for the treatment of HIV, AGS-004, demonstrated positive outcomes with the primary endpoint of viral load control and a favorable safety and immunogenicity profile in a final analysis of a Phase 2a clinical trial.

3 Mar 2011

Warwick begins research, training program to reduce pregnant mother, baby death rates in Malawi

Warwick Medical School has just begun a -2.6 million three year research and training programme to train Malawian clinical officers in a bid to reduce the country's high death rate for pregnant mothers and babies.

3 Mar 2011

New study: Talk Test is a useful indicator of VT in trained athletes

The "Talk Test" provides a simple and reliable indicator of the proper training intensity for runners, suggests a report in the March issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

3 Mar 2011

Sarsia grants BerGenBio NOK7 million to continue CellSelect advanced technology platform

BerGenBio has secured NOK7 million from local Sarsia Seed and Development funds to continue its leading research and development activities into new and original cancer treatments.

3 Mar 2011

ContextVision launches MAMMO PlusViewCAD breast cancer detection tool at ECR

ContextVision is pleased to a announce that today at the ECR in Vienna, it is officially launching the first product stemming from its recently announced strategic alliance with NeuSoft Medical Technologies.

3 Mar 2011

Roche, OraSure receive FDA 510(k) clearance for Oral Fluid Drug Testing System

OraSure Technologies, Inc. and Roche announced today that the U.S. Food and Drug Administration has granted the Companies 510(k) clearance on four homogeneous fully automated oral fluid drugs of abuse assays developed to be used exclusively as part of OraSure's Intercept Oral Fluid Drug Testing System.

3 Mar 2011

ContextVision launches GOPView iRVUltra product at 2011 ECR annual meeting

ContextVision is pleased to announce the showcasing and market launch of a second new product at the 2011 European Congress of Radiology in Vienna.

3 Mar 2011

New insight: p53 protein controls molecular crossroads in glucose metabolic pathway

The gene for the protein p53 is the most frequently mutated in human cancer. It encodes a tumor suppressor, and traditionally researchers have assumed that it acts primarily as a regulator of how genes are made into proteins.

3 Mar 2011

NHCAA's Seven Guiding Principles for Policymakers to combat health care fraud

As the U.S. House of Representatives Ways and Means and House Energy and Commerce Committees and the U.S. Senate Finance Committee all hold hearings today on combating health care fraud, waste, and abuse, an analysis that examines the "Seven Guiding Principles for Policymakers" to fighting health care fraud invites new questions about legislative efforts to reduce accountability and oversight of independent drugstores, the Pharmaceutical Care Management Association said today.

3 Mar 2011

Real-life scientists search for new medicinal plants in remote areas

Real-life scientists, whose work has overtones of Indiana Jones as they search for plants in remote areas of the world that could become the source of life-saving new medicines, are currently trying to figure out how a new international agreement on biodiversity will affect their work.

3 Mar 2011

SAMHSA survey: 65% of substance abuse treatment facilities accept private health insurance

A new nationwide survey of substance abuse treatment facilities reveals that in 2008 nearly two thirds accepted some private health insurance payment.

3 Mar 2011